Sofia Baka
Thessaloniki, ESYE12, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
CellVizio® System for Mesothorax Lymphadenopathy Rapid on Site, 18G needle: Pros and Cons.
Journal: Journal of Cancer
Published: April 13, 2026
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy.
Journal: The New England journal of medicine
Published: June 02, 2025
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial.
Journal: Lancet (London, England)
Published: April 01, 2025
LEAP-008: Lenvatinib Plus Pembrolizumab for Metastatic NSCLC That Has Progressed After an Anti-Programmed Cell Death Protein 1 or Anti-Programmed Cell Death Ligand 1 Plus Platinum Chemotherapy.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 25, 2025
Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015-2018 in Greece. The 'SUMMER' study: a retrospective multicenter chart review project.
Journal: Melanoma research
Published: December 13, 2023
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 18, 2023
An Easily Missed But Life-Threatening Diagnosis: A Case Report of Gorlin Syndrome.
Journal: The American journal of case reports
Published: April 24, 2023
Clinical Outcomes Beyond 1L EGFR-TKI Progression in mNSCLC: Final Results of the Real-World Study 'LUNGFUL'.
Journal: Anticancer research
Published: January 28, 2023
Real-world management patterns in EGFR-mutant advanced non-small-cell lung cancer before first-line adoption of osimertinib: the REFLECT study in Greece.
Journal: Future oncology (London, England)
Published: August 05, 2022
Idiopathic Multicentric Castleman Disease with Cutaneous Manifestation: Case Report.
Journal: Medicina (Kaunas, Lithuania)
Published: July 28, 2022
Last Updated: 09/26/2026